These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 11956499

  • 21. HIV-associated tuberculosis: diagnostic and treatment challenges.
    El-Sadr WM, Tsiouris SJ.
    Semin Respir Crit Care Med; 2008 Oct; 29(5):525-31. PubMed ID: 18810685
    [Abstract] [Full Text] [Related]

  • 22. [Isolation of an acid-alcohol resistant bacillus (BAAR) in the febrile HIV infected patients: Mycobacterium tuberculosis (MT) or Mycobacterium avium complex (MAC)?].
    Brel F, Rabaud C, May T, Hoen B, Amiel C, Burty C, Dailloux M, Canton P.
    Pathol Biol (Paris); 1995 Apr; 43(4):380-4. PubMed ID: 7567132
    [Abstract] [Full Text] [Related]

  • 23. Bone marrow aspiration, biopsy, and culture in the evaluation of HIV-infected patients for invasive mycobacteria and histoplasma infections.
    Akpek G, Lee SM, Gagnon DR, Cooley TP, Wright DG.
    Am J Hematol; 2001 Jun; 67(2):100-6. PubMed ID: 11343381
    [Abstract] [Full Text] [Related]

  • 24. Nevirapine-based antiretroviral therapy started early in the course of tuberculosis treatment in adult Malawians.
    van Oosterhout JJ, Kumwenda JJ, Beadsworth M, Mateyu G, Longwe T, Burger DM, Zijlstra EE.
    Antivir Ther; 2007 Jun; 12(4):515-21. PubMed ID: 17668560
    [Abstract] [Full Text] [Related]

  • 25. Diagnostic and management challenges for childhood tuberculosis in the era of HIV.
    Marais BJ, Graham SM, Cotton MF, Beyers N.
    J Infect Dis; 2007 Aug 15; 196 Suppl 1():S76-85. PubMed ID: 17624829
    [Abstract] [Full Text] [Related]

  • 26. Disseminated Mycobacterium avium complex infection: implications of recent clinical trials on prophylaxis and treatment.
    Benson CA.
    AIDS Clin Rev; 2007 Aug 15; ():271-87. PubMed ID: 9305452
    [Abstract] [Full Text] [Related]

  • 27. Hypercalcaemia complicating immune reconstitution in an HIV-infected patient with disseminated tuberculosis.
    Ferrand RA, Elgalib A, Newsholme W, Childerhouse A, Edwards SG, Miller RF.
    Int J STD AIDS; 2006 May 15; 17(5):349-50. PubMed ID: 16643687
    [Abstract] [Full Text] [Related]

  • 28. HIV infection-related tuberculosis: clinical manifestations and treatment.
    Sterling TR, Pham PA, Chaisson RE.
    Clin Infect Dis; 2010 May 15; 50 Suppl 3():S223-30. PubMed ID: 20397952
    [Abstract] [Full Text] [Related]

  • 29. Disseminated mycobacterium avium-intracellulare complex (MAC) infection in the era of effective antiretroviral therapy: is prophylaxis still indicated?
    Lange CG, Woolley IJ, Brodt RH.
    Drugs; 2004 May 15; 64(7):679-92. PubMed ID: 15025543
    [Abstract] [Full Text] [Related]

  • 30. Nontuberculous mycobacterial immune reconstitution syndrome in HIV-infected patients: spectrum of disease and long-term follow-up.
    Phillips P, Bonner S, Gataric N, Bai T, Wilcox P, Hogg R, O'Shaughnessy M, Montaner J.
    Clin Infect Dis; 2005 Nov 15; 41(10):1483-97. PubMed ID: 16231262
    [Abstract] [Full Text] [Related]

  • 31. Highly active antiretroviral therapy (HAART) in adults with tuberculosis: current status.
    Kwara A, Flanigan TP, Carter EJ.
    Int J Tuberc Lung Dis; 2005 Mar 15; 9(3):248-57. PubMed ID: 15786886
    [Abstract] [Full Text] [Related]

  • 32. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
    Pozio E.
    Parassitologia; 2004 Jun 15; 46(1-2):89-93. PubMed ID: 15305694
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. A diagnostic dilemma in a patient receiving antiretroviral and antituberculosis therapy.
    Vallabhaneni S, Kumarasamy N, Wing EJ, Flanigan TP.
    AIDS Read; 2005 Feb 15; 15(2):72-5. PubMed ID: 15712396
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Treatment outcome of HIV-associated tuberculosis in a resource-poor setting.
    Ifebunandu NA, Ukwaja KN, Obi SN.
    Trop Doct; 2012 Apr 15; 42(2):74-6. PubMed ID: 22431822
    [Abstract] [Full Text] [Related]

  • 38. [The specific features of the detection, clinical manifestations, and treatment of tuberculosis in the HIV-infected].
    Erokhin VV, Kornilova ZKh, Alekseeva LP.
    Probl Tuberk Bolezn Legk; 2005 Apr 15; (10):20-8. PubMed ID: 16318255
    [Abstract] [Full Text] [Related]

  • 39. Pneumonia in HIV-infected patients in the HAART era: incidence, risk, and impact of the pneumococcal vaccination.
    López-Palomo C, Martín-Zamorano M, Benítez E, Fernández-Gutiérrez C, Guerrero F, Rodríguez-Iglesias M, Girón-González JA.
    J Med Virol; 2004 Apr 15; 72(4):517-24. PubMed ID: 14981752
    [Abstract] [Full Text] [Related]

  • 40. Discontinuation of primary prophylaxis against Mycobacterium avium complex infection in HIV-infected persons receiving antiretroviral therapy: observations from a large national cohort in the United States, 1992-2002.
    Brooks JT, Song R, Hanson DL, Wolfe M, Swerdlow DL, Adult and Adolescent Spectrum of Disease Working Group.
    Clin Infect Dis; 2005 Aug 15; 41(4):549-53. PubMed ID: 16028167
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.